Molecular mechanisms of DNA damage induced by procarbazine in the presence of Cu(II)OGAWA, Kazuhiko; HIRAKU, Yusuke; OIKAWA, Shinji et al.Mutation research. Genetic toxicology and environmental mutagenesis. 2003, Vol 539, Num 1-2, pp 145-155, issn 1383-5718, 11 p.Article

INDUCTION OF UNRESPONSIVENESS TO SKIN AND HEART ALLOGRAFTS IN MICE BY A SYNERGISTIC TREATMENT WITH PROCARBAZINE, ANTILYMPHOCYTE SERUM, AND DONOR-TYPE CELLS = INDUCTION D'AREACTIVITE VIS-A-VIS D'ALLOGREFFES DE PEAU ET DE COEUR CHEZ LA SOURIS AU MOYEN D'UN TRAITEMENT SYNERGIQUE PAR PROCARBAZINE, SERUM ANTI-LYMPHOCYTES ET CELLULES DU TYPE DU DONNEURFLOERSHEIM GL.1973; TRANSPLANTATION; U.S.A.; DA. 1973; VOL. 15; NO 2; PP. 195-205; BIBL. 1P.Serial Issue

Reactions of OH-radicals with procarbazine. A pulse radiolysis and computer simulation studyDELIPETAR-GRUDL, A; SOLAR, S; GETOFF, N et al.Anticancer research. 2006, Vol 26, Num 1A, pp 405-410, issn 0250-7005, 6 p.Article

The effect of enzyme-inducing antiseizure drugs on the pharmacokinetics and tolerability of procarbazine hydrochlorideGROSSMAN, Stuart A; CARSON, Kathryn A; BATCHELOR, Tracy T et al.Clinical cancer research. 2006, Vol 12, Num 17, pp 5174-5181, issn 1078-0432, 8 p.Article

NOA-05 Phase 2 Trial of Procarbazine and Lomustine Therapy in Gliomatosis CerebriGLAS, Martin; BAHR, Oliver; FIMMERS, Rolf et al.Annals of neurology. 2011, Vol 70, Num 3, pp 445-453, issn 0364-5134, 9 p.Article

DIE BEHANDLUNG DER MAKROGLOBULINAEMIE WALDENSTROEM MIT PROCARBAZIN = TRAITEMENT DE LA MACROGLOBULINEMIE DE WALDENSTROEM PAR LA PROCARBAZINEMITROU P; SCHUBERT JCF; MARTIN H et al.1972; DTSCHE MED. WSCHR.; DTSCH.; DA. 1972; VOL. 97; NO 48; PP. 1864-1869; ABS. ANGL.; BIBL. 17REF.Serial Issue

PROCARBAZINESPIVACK SD.1974; ANN. INTERN. MED.; U.S.A.; DA. 1974; VOL. 81; NO 6; PP. 795-800; BIBL. 1P.Article

THE EFFECT OF PROCARBAZINE ON THE CHROMOSOMES OF NORMAL AND MALIGNANT MOUSE CELLS.RAPP M; THERMAN E.1977; ANN. GENET.; FR.; DA. 1977; VOL. 20; NO 4; PP. 249-254; ABS. FR.; BIBL. 20 REF.Article

Procarbazine hypersensitivity manifested as a fixed drug eruptionGIGUERE, J. K; DOUGLAS, D. M; LUPTON, G. P et al.Medical and pediatric oncology. 1988, Vol 16, Num 6, pp 378-380, issn 0098-1532Article

L'EFFET THERAPEUTIQUE DU NATULAN DANS LES FORMES GENERALISEES DE LYMPHOGRANULOMATOSEVINOKUROVA NA; GERSHANOVICH ML.1974; VOPR. ONKOL.; S.S.S.R.; DA. 1974; VOL. 20; NO 8; PP. 7-13; ABS. ANGL; BIBL. 1P.Article

Chemotherapy for diffuse low-grade gliomas in adultsDUCRAY, F.Revue neurologique (Paris). 2011, Vol 167, Num 10, pp 673-679, issn 0035-3787, 7 p.Conference Paper

Procarbazine in haematology: an old drug with a new life?MASSOUD, M; ARMAND, J. P; RIBRAG, V et al.European journal of cancer (1990). 2004, Vol 40, Num 13, pp 1924-1927, issn 0959-8049, 4 p.Article

PROCARBAZINE HYDROCHLORIDE IN THE TREATMENT OF BRAIN TUMORS. PHASE 2 STUDY = HYDROCHLORIDE DE PROCARBAZINE DANS LE TRAITEMENT DES TUMEURS CEREBRALESVASANTHA KUMAR AR; RENAUDIN J; WILSON CB et al.1974; J. NEUROSURG.; U.S.A.; DA. 1974; VOL. 40; NO 3; PP. 365-371; BIBL. 9REF.Article

The emerging role of reactive oxygen species in cancer therapyRENSCHLER, Markus F.European journal of cancer (1990). 2004, Vol 40, Num 13, pp 1934-1940, issn 0959-8049, 7 p.Article

ZYTOSTATISCHE THERAPIE DER LYMPHOGRANULOMATOSE = LE TRAITEMENT CYTOSTATIQUE DE LA LYMPHOGRANULOMATOSEKONRAD H; ENGELMANN C; ZUBAIDI G et al.1972; Z. GES. INNERE MED.; DTSCH.; DA. 1972; VOL. 27; NO 23; PP. 1035-1039; ABS. RUSSE ANGL.; BIBL. 30 REF.Serial Issue

TIRCHLORTRIETHYLAMINE (TS-160 SPOFA) IN COMBINATION CHEMOTHERAPY OF MALIGNANT LYMPHOMASKLENER P; DONNER L.1975; NEOPLASMA; TCHECOSL.; DA. 1975; VOL. 22; NO 1; PP. 55-62; BIBL. 1 P.Article

ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEDE VITA VT JR; CANELLOS GP; CHABNER B et al.1975; LANCET; G.B.; DA. 1975; NO 7901; PP. 248-250; BIBL. 18REF.Article

COMBINATION CHEMOTHERAPY OF HODG-KIN'S DISEASE IN PRIVATE PRACTICE = CHIMIOTHERAPIE ASSOCIEE DE LA MALADIE DE HODGKIN EN PRATIQUE PRIVEEGREENBERG LH; STUART WONG Y; RICHARDSON AP JR et al.1972; J. AMER. MED. ASS.; U.S.A.; DA. 1972; VOL. 221; NO 3; PP. 261-623; BIBL. 7 REF.Serial Issue

ACTION DU 1-METHYL-2-(P-ISOPROPYL-CARBAMOYL-BENZYL)-HYDRAZINE SUR LE DNA, IN VITRO ET IN VIVO (CELLULES EN CULTURE)AUDUBERT F.1972; BIOCHEM. BIOPHYS. ACTA; PAYS-BAS; DA. 1972; VOL. 281; NO 4; PP. 507-513; ABS. ANGL.; BIBL. 11REF.Serial Issue

Development of the acrosome and alignment elongation and entrenchment of spermatids in procarbazine-treated ratsRUSSELL, L. D; LEE, I. P; ETTLIN, R et al.Tissue & cell. 1983, Vol 15, Num 4, pp 615-626, issn 0040-8166Article

ETUDE DES EFFETS D'UN AGENT RADIOMIMETIQUE (PROCARBAZINE) SUR LA CINETIQUE DE CROISSANCE D'AZOTOBACTER CHROOCOCCUM. INTERACTIONS CELLULAIRES ET RESISTANCE AU MILIEU1972; AO-CNRS-6725; FR.; DA. 1972; PP. 1-238; BIBL. 16P.; THESE DOCT. SCI. NAT.; UNIV. CAEN; 1972Thesis

EFFECT OF CYTOSTATICS ON THE MIGRATION OF LEUKOCYTESHORVATH M; BAKACS T.1982; ONCOLOGY; ISSN 0030-2414; CHE; DA. 1982; VOL. 39; NO 1; PP. 29-30; BIBL. 6 REF.Article

COMBINATION CHEMOTHERAPY OF LYMPHOMAS OTHER THAN HODGKIN'S DISEASESTEIN RS; MORAN EM; DESSER RK et al.1974; ANN. INTERN. MED.; U.S.A.; DA. 1974; VOL. 81; NO 5; PP. 601-608; BIBL. 31REF.Article

NEUROTOXICITY OF COMMONLY USED ANTINEOPLASTIC AGENTS. II = NEUROTOXICITY DES AGENTS ANTINEOPLASTIQUES COURAMMENT UTILISES. IIWEISS HD; WALKER MD; WIERNIK PH et al.1974; NEW ENGL. J. MED.; U.S.A.; DA. 1974; VOL. 291; NO 3; PP. 127-133; BIBL. 1P.Article

A DECADE OF COMBINATION CHEMOTHERAPY OF ADVANCED HODGKIN'S DISEASEDEVITA VT JR; CANELLOS GP; MOXLEY JH III et al.1972; CANCER; U.S.A.; DA. 1972; VOL. 30; NO 6; PP. 1495-1504; BIBL. 35 REF.Serial Issue